Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma

NCT06741020 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)

Interventions

DRUG: Adebrelimab, Oxaliplatin, Fluorouracil,Leucovorin

Sponsor

Zhejiang Cancer Hospital